Evaluation of genes identified by microarray analysis in favorable neuroblastoma
- 23 August 2009
- journal article
- research article
- Published by Springer Nature in Pediatric Surgery International
- Vol. 25 (11) , 931-937
Abstract
The biological heterogeneity of neuroblastoma results in a varied outcome ranging from spontaneous regression to fatal tumor progression. Microarray expression profiling and genetic polymorphism arrays may help identify key genes that differ in aggressive neuroblastomas from those observed in tumors associated with a favorable outcome.Keywords
This publication has 14 references indexed in Scilit:
- Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancersMolecular Cancer Therapeutics, 2006
- Mutational screening of theCYP26A1gene in patients with caudal regression syndromeBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Differentially expressed genes throughout the cellular immortalization processes are quite different between normal human fibroblasts and endothelial cellsInternational Journal of Oncology, 2005
- Gene expression profiling and identification of novel prognostic marker genes in neuroblastomaGenes, Chromosomes and Cancer, 2004
- Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activityJournal of Pediatric Surgery, 2003
- Expression profiling of favorable and unfavorable neuroblastomasPediatric Surgery International, 2003
- Developing with lethal RA levels: genetic ablation ofRargcan restore the viability of mice lackingCyp26a1Development, 2003
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Genetic parameters of neuroblastomasCancer Letters, 2002
- Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse developmentNature Genetics, 2002